← Eichor
Study identifier: NCT06320041 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery

Condition: Postoperative Pain  ·  Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine

PhasePhase 4
Planned participants162
Who can joinAll sexes, 18 Years to 100 Years
Healthy volunteersNo

About this study

The goal of this clinical trial\] is to further explore the effectiveness and safety of oxelidine in the treatment of moderate to severe acute pain after orthopedic surgery. The main question it aims to answer is: Pain management after orthopaedic surgery provides more effective and safe drug options, provides new options for clinical treatment, and provides a scientific basis for clinical practice. Participants will be asked to pain score in the different time, treatments they'll be given and use optimal drug. Researchers will compare analgesic effect of oxelidine of different dose.

This description comes directly from the study's public registry record.

Talk to the study team

Dongmei Ma  ·  +8615267358077  ·  8019111@zju.edu.cn

Li Li  ·  +8618267858561  ·  65602423@qq.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Fourth Affiliated Hospital of Zhejiang University School of MedicineYiwu, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06320041